Insider buying on Sep 2, 2026
Insiders at 32 companies reported 54 open-market buys of their own stock on Sep 2, 2026. Plan trades are left out.
Newest first
WhoTradeCompanyValueTradedThe stock’s closing price from the first session on or after the trade day to the latest close, with the S&P 500 over the same days. A fact about the stock, not a result anyone earned.
Ashley B. SmithChief Executive OfficerBoughtRaised their holding by 0.7%
Smith MidlandSMID$9.8K1,275 shares at $7.69Dec 7, 20187y agoStock since trade+176.4%Dec 7, 2018 close $7.67 → Oct 26, 2026 close $21.20. S&P 500 +188.3% over the same days.
Mauad Bruno SousaDirectorBought
Aura MineralsAUGO$798.9010 shares at $79.89Aug 3158d agoStock since trade−7.7%Aug 31, 2026 close $83.58 → Oct 26, 2026 close $77.13. S&P 500 −0.9% over the same days.
C. Bradford RichmondDirectorBoughtRaised their holding by 1.4%
BJS RestaurantsBJRI$30.5K500 shares at $61.05Sep 256d agoStock since trade−4.6%Sep 2, 2026 close $60.71 → Oct 26, 2026 close $57.91. S&P 500 −0.7% over the same days.
Kelly GoldChief Financial OfficerBoughtNew holding
CAMP4 TherapeuticsCAMP$39.6K10,000 shares at $3.96Aug 3158d agoStock since trade−16.8%Aug 31, 2026 close $3.96 → Oct 23, 2026 close $3.29. S&P 500 −0.9% over the same days.
Liane Rae TeplitskyChief Operating OfficerBoughtRaised their holding by 32%
Pulse BiosciencesPLSE$50K1,001 shares at $49.95Sep 157d agoStock since trade+1.1%Sep 1, 2026 close $52.09 → Oct 26, 2026 close $52.66. S&P 500 −0.2% over the same days.
Liane Rae TeplitskyChief Operating OfficerBoughtRaised their holding by 49%Pulse BiosciencesPLSE$50K1,024 shares at $48.80Aug 3158d agoStock since trade+4.6%Aug 31, 2026 close $50.33 → Oct 26, 2026 close $52.66. S&P 500 −0.9% over the same days.
Michael HeltzenChief Executive OfficerBoughtRaised their holding by 1.7%
ExozymesEXOZ$1.9K250 shares at $7.60Aug 2663d agoStock since trade−50.2%Aug 26, 2026 close $7.53 → Oct 26, 2026 close $3.75. S&P 500 −0.8% over the same days.
Michael HeltzenChief Executive OfficerBoughtRaised their holding by 1.7%ExozymesEXOZ$1.8K251 shares at $7.35Aug 2663d agoStock since trade−50.2%Aug 26, 2026 close $7.53 → Oct 26, 2026 close $3.75. S&P 500 −0.8% over the same days.
Michael HeltzenChief Executive OfficerBoughtExozymesEXOZ$30.324 shares at $7.58Aug 2663d agoStock since trade−50.2%Aug 26, 2026 close $7.53 → Oct 26, 2026 close $3.75. S&P 500 −0.8% over the same days.
Michael HeltzenChief Executive OfficerBoughtRaised their holding by 0.7%ExozymesEXOZ$750.00100 shares at $7.50Aug 2564d agoStock since trade−50.2%Aug 25, 2026 close $7.53 → Oct 26, 2026 close $3.75. S&P 500 −0.8% over the same days.